Samuel Katz, MD, PhD

Associate Professor Term

Research Interests

Leukemia; Lymphoma; Stem Cells; Cell Death; Apoptosis; Genes, bcl-2; Endoplasmic Reticulum Stress

Research Organizations

Pathology: Katz Lab | Pathology Research

Yale Cancer Center: Genomics, Genetics, and Epigenetics

Office of Cooperative Research

Research Summary

The goal of the Katz laboratory is to selectively control the cell death machinery for therapeutic benefit. Toward that end a multidisciplinary approach is applied to understand how mammalian cells are conditioned to expire, and how mutations in essential apoptotic regulators lead to developmental defects or malignancy. In particular, BCL-2 family proteins are vital regulators of mitochondrial integrity and have been implicated in the development, maintenance and chemoresistance of numerous cancers. While the basic mode of BCL-2 family action is established, how this pathway is integrated in the context of various cellular programs, including alternate survival and death pathways, is not nearly as well understood.

Thus, we focus on:

  1. severe apoptotic blockades in cancer stem cells;
  2. loss of pro-apoptotic BCL-2 family members in mantle cell lymphoma as well as other cancers; and
  3. the mechanism of key understudied family members.

Selected Publications

Full List of PubMed Publications

Edit this profile

Contact Info

Samuel Katz, MD, PhD
Patient Care Location
Yale PathologyYale New Haven Hospital
20 York Street, Ste East Pavilion 2-631

New Haven, CT 06510
View on map...
Mailing Address
Pathology310 Cedar Street
PO Box 208023

New Haven, CT 06520-8023

Katz Lab